1. Yuan, Lin, Yang, Zhenyu, Zhao, Jing, Shen, Zhen, Yu, Guanying. 2022. Pan-Cancer Bioinformatics Analysis of Gene UBE2C. In Frontiers in genetics, 13, 893358. doi:10.3389/fgene.2022.893358. https://pubmed.ncbi.nlm.nih.gov/35571064/
2. Zhang, Shizhen, You, Xiahong, Zheng, Yawen, Xiong, Xiufang, Sun, Yi. 2023. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells. In The Journal of clinical investigation, 133, . doi:10.1172/JCI162434. https://pubmed.ncbi.nlm.nih.gov/36548081/
3. Chen, Zhiping, Wang, Lanfeng. 2021. The clinical significance of UBE2C gene in progression of renal cell carcinoma. In European journal of histochemistry : EJH, 65, . doi:10.4081/ejh.2021.3196. https://pubmed.ncbi.nlm.nih.gov/33782624/
4. Wang, Yan, Wang, Jili, Tang, Qiusu, Ren, Guoping. 2021. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis. In PloS one, 16, e0247827. doi:10.1371/journal.pone.0247827. https://pubmed.ncbi.nlm.nih.gov/33630978/
5. Li, Wenjie, Chen, Changhao, Zheng, Hanhao, Lan, Tianhang, He, Wang. 2024. UBE2C-induced crosstalk between mono- and polyubiquitination of SNAT2 promotes lymphatic metastasis in bladder cancer. In The Journal of clinical investigation, 134, . doi:10.1172/JCI179122. https://pubmed.ncbi.nlm.nih.gov/38949026/
6. Lv, Zhengtong, Wang, Miao, Hou, Huimin, Wang, Jianye, Liu, Ming. 2023. FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway. In International journal of biological sciences, 19, 3293-3306. doi:10.7150/ijbs.84067. https://pubmed.ncbi.nlm.nih.gov/37496990/
7. Huang, Renlun, Guo, Lang, Chen, Chiwei, Gao, Wenxi, Xiang, Songtao. 2023. System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma. In PloS one, 18, e0289418. doi:10.1371/journal.pone.0289418. https://pubmed.ncbi.nlm.nih.gov/37535572/
8. Zhao, Rong, Liu, Yan, Wang, Ziwei, Feng, Dilu, Wang, Hongbo. . UBE2C-mediated Autophagy Inhibition via Ubiquitination of SIRT1 Contributes to Endometrial Cancer Progression. In Molecular cancer research : MCR, 21, 564-577. doi:10.1158/1541-7786.MCR-22-0825. https://pubmed.ncbi.nlm.nih.gov/36930831/
智鼠故事 
